No Data
Press Release: Personalis to Announce Second Quarter 2024 Financial Results
Even After Rising 48% This Past Week, Personalis (NASDAQ:PSNL) Shareholders Are Still Down 89% Over the Past Three Years
A Piece Of The Puzzle Missing From Personalis, Inc.'s (NASDAQ:PSNL) 28% Share Price Climb
Express News | Myriad Genetics And Personalis Announce Cross-Licensing Agreement For Tumor-Informed MRD Detection Patents; Agreement Enhances Freedom To Operate In MRD Market And Broadens Patient Access To MRD Testing Benefits
Express News | Personalis 13D Filing Shows Tempus AI Reported A 15.1% Stake In The Co As Of July 3, 2024
Express News | Ravi Mhatre - Will Seek to Engage in Dialogue With Personalis’ Board and/or Management About Strategic Opportunities to Maximize Co's Shareholder Value
No Data
